Pro-Dex, Inc. (PDEX)
66.26
+0.59
(+0.90%)
USD |
NASDAQ |
Aug 24, 16:00
66.26
0.00 (0.00%)
After-Hours: 20:00
Pro-Dex Enterprise Value : 219.11M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 219.11M |
| August 20, 2026 | 221.16M |
| August 19, 2026 | 223.17M |
| August 18, 2026 | 223.01M |
| August 17, 2026 | 223.84M |
| August 14, 2026 | 223.43M |
| August 13, 2026 | 226.24M |
| August 12, 2026 | 224.68M |
| August 11, 2026 | 222.47M |
| August 10, 2026 | 220.98M |
| August 07, 2026 | 218.76M |
| August 06, 2026 | 218.51M |
| August 05, 2026 | 221.13M |
| August 04, 2026 | 227.97M |
| August 03, 2026 | 212.53M |
| July 31, 2026 | 196.42M |
| July 30, 2026 | 190.28M |
| July 29, 2026 | 184.62M |
| July 28, 2026 | 189.29M |
| July 27, 2026 | 192.23M |
| July 24, 2026 | 184.78M |
| July 23, 2026 | 183.95M |
| July 22, 2026 | 179.99M |
| July 21, 2026 | 188.23M |
| July 20, 2026 | 183.92M |
| Date | Value |
|---|---|
| July 17, 2026 | 192.61M |
| July 16, 2026 | 198.05M |
| July 15, 2026 | 189.93M |
| July 14, 2026 | 195.43M |
| July 13, 2026 | 205.94M |
| July 10, 2026 | 210.23M |
| July 09, 2026 | 207.51M |
| July 08, 2026 | 200.25M |
| July 07, 2026 | 197.38M |
| July 06, 2026 | 206.84M |
| July 02, 2026 | 205.24M |
| July 01, 2026 | 209.75M |
| June 30, 2026 | 196.35M |
| June 29, 2026 | 195.86M |
| June 26, 2026 | 205.69M |
| June 25, 2026 | 217.96M |
| June 24, 2026 | 216.08M |
| June 23, 2026 | 211.83M |
| June 22, 2026 | 215.05M |
| June 18, 2026 | 214.96M |
| June 17, 2026 | 202.46M |
| June 16, 2026 | 208.41M |
| June 15, 2026 | 212.88M |
| June 12, 2026 | 208.02M |
| June 11, 2026 | 210.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.49B |
| AngioDynamics, Inc. | 613.87M |
| Alphatec Holdings, Inc. | 1.956B |
| AtriCure, Inc. | 2.398B |
| Baxter International, Inc. | 20.30B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.938M |
| Revenue (Quarterly) | 19.95M |
| Total Expenses (Quarterly) | 16.01M |
| EPS Diluted (Quarterly) | 1.204 |
| Gross Profit Margin (Quarterly) | 30.74% |
| Profit Margin (Quarterly) | 19.74% |
| Earnings Yield | 5.47% |
| Operating Earnings Yield | 4.92% |
| Normalized Earnings Yield | 4.282 |